# @elilillyco on Instagram

- **Type:** Image
- **Original URL:** https://www.instagram.com/p/Dd3713WlwdY
- **Gondola URL:** https://gondola.cc/posts/71215681-elilillyco-instagram
- **Thumbnail:** https://img.gondola.cc/tr:w-,h-,fo-auto/postThumbnails/c27d7e580a.jpg
- **Posted:** 2026-09-29T15:00:01.000+00:00
- **Account Owner:** Eli Lilly and Company (@elilillyco) — https://gondola.cc/elilillyco

## Caption

New information for HCPs: A new indirect treatment comparison presented at the #EASD2026 annual meeting compared the highest dose of our dual GIP/GLP-1 obesity medicine with the highest dose of another obesity medicine. This analysis reflects our commitment to providing clinicians with evidence to support treatment decisions. Read more at the link in our bio.

## Stats

- **Views:** 0
- **Likes:** 249
- **Shares:** 0
- **Comments:** 12

## Tags

easd2026

---
Copyright (c) Gondola